Mixed Reality in MitraClip Implantation: Preliminary Case Series
Recruiting
Observational Study
Mitral Regurgitation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 14 (estimated)
- Sponsor
- Nemocnice AGEL Trinec-Podlesi a.s. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to evaluate the impact of mixed reality (MR) technology, particularly using Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, on MitraClip implantation procedures. This preliminary case series includes a comparative analysis of four MitraClip implantations, assessing procedural efficiency, radiation exposure, and operator stress through both phys…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged over 18 years
* Patients diagnosed with mitral valve regurgitation requiring MitraClip implantation
* Ability to provide informed consent and comply with study procedures
Exclusion Criteria:
* Patients with contraindications for MR technology (e.g., MRI incompati…
Contacts